Solventum Corp | SOLV - Equity Capital And Reserves


Solventum Corp reported $4.97B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Cencora USD 1.91B 400.31M Dec/2025
Dexcom USD 2.96B 210.9M Mar/2026
Insulet USD 1.3B 212.6M Mar/2026
Solventum Corp USD 4.97B 80M Mar/2026
West Pharmaceutical Services USD 2.99B 185.6M Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026